Anxious-retarded depression: Relation with plasma vasopressin and cortisol

Neuropsychopharmacology

Volumn 28, Issue 1, 2003, Pages 140-147

  de Winter, Remco F P ^a,b   Van Hemert, Albert M ^b   Derijk, Roel H ^b   Zwinderman, Koos H ^b   Frankhuijzen Sierevoge, Ank C ^c   Wiegant, Victor M ^c   Goekoop, Jaap G ^a,b  

^a Rijngeest Groep   (Netherlands)

^b LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^c UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

Anxiety; Cortisol; Depression; Melancholia; Retardation; Vasopressin

Indexed keywords

BIOLOGICAL MARKER; HYDROCORTISONE; VASOPRESSIN DERIVATIVE;

ADULT; ANXIETY; ARTICLE; BLOOD; CLINICAL TRIAL; CROSSOVER PROCEDURE; DEPRESSION; FEMALE; FOLLOW UP; HUMAN; MALE; MIDDLE AGED; PROSPECTIVE STUDY; PSYCHOLOGICAL ASPECT; PSYCHOLOGICAL RATING SCALE;

ADULT; ANXIETY; BIOLOGICAL MARKERS; CROSS-OVER STUDIES; DEPRESSIVE DISORDER; FEMALE; FOLLOW-UP STUDIES; HUMANS; HYDROCORTISONE; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; PSYCHIATRIC STATUS RATING SCALES; VASOPRESSINS;

EID: 0037209289     PISSN: 0893133X     EISSN: 1740634X     Source Type: Journal    
DOI: 10.1038/sj.npp.1300002     Document Type: Article

References (50)

1. Altemus M, Cizza G, Gold PW (1992). Chronic fluoxetine treatment reduces hypothalamic vasopressin secretionin vitro.Brain Res593: 311-313.
2. Altemus M, Cizza G, Gold PW American Psychiatric Association (1980).Diagnostic and Statistical Manual of Mental Disorders.3rd edn. American Psychiatric Press: Washington DC.
3. Altemus M, Cizza G, Gold PW American Psychiatric Association (1994).Diagnostic and Statistical Manual of Mental Disorders.4th edn. Washington, DC: American Psychiatric Press.
4. Amin ES, El Sayed MM, El Gamel BA, Nayel SA (1980).Comparative study of the effect of oral contraceptives containing50 microgram of estrogen and those containing 20 microgram ofestrogen on adrenal cortical function.Am J ObstetGynecol137:831-833.
5. Antoni FA (1993). Vasopressinergic control of pituitary adreno-corticotropin secretion comes of age.Front Neuroendocrinol14: 76-122.
6. Asberg M, Montgomery SA, Perris C, Schalling D, Sedvall G (1978). A comprehensive psychopathological rating scale.ActaPsychiatrScand271(Suppl): 5-27.
7. Bohus B, Koolhaas JM (1993). Stress and the cardiovascular system: central and peripheral mechanisms. In: Stanford SC, Salmon P (eds).Stress.From Synapse to Syndrome. AcademicPress Harcourt and Company: London, pp 75-118.
8. Carroll BJ, Curtis GC, Davies BM, Mendels J, Sugerman AA (1976a). Urinary free cortisol excretion in depression.PsycholMed6: 43-50.
9. Carroll BJ, Curtis GC, Mendels J (1976b). Cerebrospinal fluid and plasma free cortisol concentrations in depression.Psychol Med6: 235-244.
10. Carroll BJ, Feinberg M, Greden JF, Tarika J, Albala AA, Haskett RFet al(1981). A specific laboratory test for the diagnosis ofmelancholia.Standardization, validation, and clinical utility.Arch Gen Psychiatr38: 15-22.
11. Clark LA, Watson D (1991). Tripartite model of anxiety and depression: psychometric evidence and taxonomic implications.J AbnormPsychol100: 316-336.
12. deGoeij DC, Jezova D, Tilders FJ (1992). Repeated stress enhances vasopressin synthesis in corticotropin releasing factor neuronsin the paraventricular nucleus.Brain Res577: 165-168.
13. Ekstrom P, Akerlund M, Forsling M, Kindahl H, Laudanski T, Mrugacz G (1992). Stimulation of vasopressin release in womenwith primary dysmenorrhoea and after oral contraceptivetreatment-effect on uterine contractility.Br J ObstetGynaecol99: 680-684.
14. Gattaz WF, Hannak D, Beckmann H (1985). Increased CSF cortisol levels after neuroleptic treatment in schizophrenia.Psychoneur-oendocrinology10: 351-354.
15. Glanzer K, Appenheimer M, Kruck F, Vetter W, Vetter H (1984). Measurement of 8-arginine-vasopressin by radioimmunoassay.Development and application to urine and plasma samples usingone extraction method.ActaEndocrinol106: 317-329.
16. Goekoop JG, Hoeksema T, Knoppert-Van der Klein EA, Klinkhamer RA, Van Gaalen HA, Van Londen Let al(1992). Multi-dimensional ordering of psychopathology. A factor-analytic study using the Comprehensive Psychopathological Rating Scale.ActaPsychiatrScand86: 306-312.
17. Goekoop JG, Knoppert-Van der Klein EA, Hoeksema T, Klinkhamer RA, Van Gaalen HA, van der Velde EA (1991). The interraterreliability of a Dutch version of the Comprehensive Psycho-pathological Rating Scale.ActaPsychiatrScand83: 202-205.
18. Goekoop JG, Knoppert-Van der Klein EA, Hoeksema T, Zwinderman AH (1994).Onderzoek met de CPRS in Nederlandsevertaling.Betrouwbaarheid, factorstructuur en intensiteitsbeoordeling.Tijdschriftvoor Psychiatrie36: 520-526.
19. Goekoop JG, Zwinderman AH (1994).Multidimensional hierarchic ordering of psychopathology.Rasch analysis in factor-analyticdimensions.ActaPsychiatrScand90: 399-404.
20. Guillon G, Trueba M, Joubert D, Grazzini E, Chouinard L, Cote Met al(1995). Vasopressin stimulates steroid secretion in humanadrenal glands: comparison with angiotensin-II effect.Endocri-nology136: 1285-1295.
21. Hatzinger M, Wotjak CT, Naruo T, Simchen R, Keck ME, Landgraf Ret al(2000). Endogenous vasopressin contributes to hypothalamic-pituitary-adrenocortical alterations in aged rats.J Endocrinol164: 197-205.
22. Heuser I, Yassouridis A, Holsboer F (1994). The combined dexamethasone/CRH test: a refined laboratory test for psychiatricdisorders.J Psychiatr Res28: 341-356.
23. Holsboer, F (1999). The rationale for corticotropin-releasing hormone receptor (CRH-R) antagonists to treat depressionand anxiety.J Psychiatr Res33: 181-214.
24. Inder WJ, Donald RA, Prickett TC, Frampton CM, Sullivan PF, Mulder RT, Joyce PR (1997). Arginine vasopressin is associatedwith hypercortisolemia and suicide attempts in depression.BiolPsychiatry42: 744-747.
25. Keck ME, Wigger A, Welt T, Muller MB, Gesing A, Reul JMet al(2002). Vasopressin mediates the response of the combineddexamethasone/CRH test in hyper-anxious rats: implications forpathogenesis of affective disorders.Neuropsychopharmacology26: 94-105.
26. Kiss JZ, Mezey E, Skirboll L (1984). Corticotropin-releasing factor-immunoreactive neurons of the paraventricular nucleus become vasopressin positive after adrenalectomy.ProcNatlAcadSciUSA81: 1854-1858.
27. Kostoglou-Athanassiou I, Athanassiou P, Treacher DF, Wheeler MJ, Forsling ML (1998).Neurohypophysial hormone andmelatonin secretion over the natural and suppressed menstrualcycle in premenopausal women.ClinEndocrinol49: 209-216.
28. Kovacs KJ, Foldes A, Sawchenko PE (2000). Glucocorticoid negative feedback selectively targets vasopressin transcriptionin parvocellularneurosecretory neurons.J Neurosci20: 3843-3852.
29. Kraus RP, Grof P (1985). Discontinuation of drugs and DST results.Am J Psychiatry142: 518.
30. Maes M, Meltzer HY, Cosyns P, Schotte C (1994). Evidence for the existence of major depression with and without anxiety features.Psychopathology27: 1-13.
31. Modell S, Yassouridis A, Huber J, Holsboer F (1997). Corticosteroid receptor function is decreased in depressed patients.Neuroen-docrinology65: 216-222.
32. Moleman P, Birkenhaeger TK (1998).Praktischepsychofarmacolo-gie. Bohn Stafleu Van Loghum: Houten.
33. Montgomery SA, Asberg M (1979). A new depression scale designed to be sensitive to change.Br J Psychiatry134: 382-389.
34. Muller MB, Landgraf R, Preil J, Sillaber I, Kresse AE, Keck MEet al(2000). Selective activation of the hypothalamic vasopressinergicsystem in mice deficient for the corticotropin-releasing hormonereceptor 1 is dependent on glucocorticoids.Endocrinology141:4262-4269.
35. Nelson JC, Davis JM (1997). DST studies in psychotic depression: a meta-analysis.Am J Psychiatry154: 1497-1503.
36. Parker G, Roy K, Hadzi-Pavlovic D, Mitchell P, Wilhelm K, Menkes DBet al(2000). Subtyping depression by clinical features: theAustralasian database.ActaPsychiatrScand101: 21-28.
37. Pitts AF, Samuelson SD, Meller WH, Bissette G, Nemeroff CB, Kathol RG (1995). Cerebrospinal fluid corticotropin-releasinghormone, vasopressin, and oxytocin concentrations in treatedpatients with major depression and controls.Biol Psychiatry38:330-335.
38. Raadsheer FC, Hoogendijk WJ, Stam FC, Tilders FJ, Swaab DF (1994). Increased numbers of corticotropin-releasinghormone expressing neurons in the hypothalamic paraventri-cular nucleus of depressed patients.Neuroendocrinology60:436-444.
39. Raskind MA, Courtney N, Murburg MM, Backus FI, Bokan JA, Ries RKet al(1987). Antipsychotic drugs and plasma vasopressin innormals and acute schizophrenic patients.Biol Psychiatry22:453-462.
40. Rush AJ, Giles DE, Schlesser MA, Orsulak PJ, Parker Jr CR, Weissenburger JEet al(1996).The dexamethasone suppressiontest in patients with mood disorders.J Clin Psychiatry57:470-484.
41. Rush AJ, Weissenburger JE (1994). Melancholic symptom features and DSM-IV.Am J Psychiatry151: 489-498.
42. Sapolsky RM, Plotsky PM (1990). Hypercortisolism and its possible neural bases.Biol Psychiatry27: 937-952.
43. Scott LV, Dinan TG (1998). Vasopressin and the regulation of hypothalamic-pituitary-adrenal axis function: implications forthe pathophysiology of depression.Life Sci62: 1985-1998.
44. Thalen BE, Kjellman BF, Ljunggren JG, Akner G, Kagedal B, Wahlund Bet al(1993). Release of corticotropin afteradministration of corticotropin- releasing hormone in depressedpatients in relation to the dexamethasone suppression test.ActaPsychiatrScand87: 133-140.
45. Ur E, Dinan TG, O’Keane V, Clare AW, McLoughlin L, Rees LHet al(1992). Effect of metyrapone on the pituitary-adrenal axis indepression: relation to dexamethasone suppressor status.Neuroendocrinology56: 533-538.
46. Van Londen L, Goekoop JG, van Kempen GM, Frankhuijzen-Sierevogel AC, Wiegant VM, van der Velde EA, De Wied D (1997). Plasma levels of arginine vasopressin elevated in patientswith major depression.Neuropsychopharmacology17: 284-292.
47. Viinamaki O, Erkkola R, Kanto J (1986). Plasma vasopressin concentrations and serum vasopressinase activity in pregnantand nonpregnant women.Biol Res Pregnancy Perinatol7:17-19.
48. Von Bardeleben U, Holsboer F, Stalla GK, Muller OA (1985). Combined administration of human corticotropin-releasingfactor and lysine vasopressin induces cortisol escape fromdexamethasone suppression in healthy subjects.Life Sci37:1613-1618.
49. Wang J, Patten SB (2001). Alcohol consumption and major depression: findings from a follow-up study.Can J Psychiatry46: 632-638.
50. Weme de RJC, Hoeksema T, Goekoop JG (1996). De Widlocherremmingsschaal, eenNederlandseschaalvoor het meten vanpsychomotoreremming.ActaNeuropsychiatrica8: 56-63.